1. Home
  2. FSSL vs BVS Comparison

FSSL vs BVS Comparison

Compare FSSL & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FS Specialty

FSSL

FS Specialty

HOLD

Current Price

$11.57

Market Cap

884.4M

Sector

Finance

ML Signal

HOLD

Logo Bioventus Inc.

BVS

Bioventus Inc.

HOLD

Current Price

$14.70

Market Cap

892.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSSL
BVS
Founded
2010
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
884.4M
892.4M
IPO Year
2025
2016

Fundamental Metrics

Financial Performance
Metric
FSSL
BVS
Price
$11.57
$14.70
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
★ $17.60
AVG Volume (30 Days)
248.1K
★ 362.4K
Earning Date
01-01-0001
11-06-2026
Dividend Yield
★ 15.05%
N/A
EPS Growth
N/A
★ 163.46
EPS
N/A
★ 0.52
Revenue
N/A
★ $568,087,000.00
Revenue This Year
N/A
$6.46
Revenue Next Year
N/A
$6.74
P/E Ratio
★ $9.70
$28.82
Revenue Growth
★ N/A
N/A
52 Week Low
$10.75
$6.47
52 Week High
$14.49
$15.89

Technical Indicators

Market Signals
Indicator
FSSL
BVS
Relative Strength Index (RSI) 48.36 61.05
Support Level $11.31 $12.43
Resistance Level $11.92 $14.92
Average True Range (ATR) 0.23 0.50
MACD 0.02 0.18
Stochastic Oscillator 45.69 76.87

Price Performance

Historical Comparison
FSSL
BVS

About FSSL FS Specialty

FS Specialty Lending Fund is a United States-based externally managed, non-diversified, closed-end management investment company. The company's investment objectives are to generate current income and, to a lesser extent, long-term capital appreciation by investing mainly in private and public credit in a broad set of industries, sectors, and sub-sectors. Its investment policy is to invest mainly in a portfolio of secured and unsecured floating and fixed-rate loans, bonds, and other types of credit instruments, which, under normal circumstances, will represent at least eighty percent of the Company's total assets.

About BVS Bioventus Inc.

Bioventus Inc is a medical device company focused on developing and commercializing products to relieve pain and address musculoskeletal conditions. The company operates through two reporting segments, U.S. and International, and its product portfolio is organized into three main business areas: Pain Treatments, Surgical Solutions, and Restorative Therapies, offering products such as hyaluronic acid injections for osteoarthritis, peripheral nerve stimulation devices, bone graft substitutes, and ultrasound-based fracture healing therapies.

Share on Social Networks: